CN Patent

CN107573341B — 作为parp抑制剂的新型稠环化合物、其制备方法和应用

Assigned to Guangzhou Dankang Medicine Biological Co ltd · Expires 2020-08-14 · 6y expired

What this patent protects

本发明公开了作为PARP抑制剂的新型稠环化合物、其制备方法和应用。本发明的稠环化合物如式I所示。本发明的稠环化合物具有PARP抑制活性，为PARP抑制剂提供了一种新的商业选择，可用于治疗和/或预防肿瘤、中风、心肌缺血、炎症或糖尿病。

USPTO Abstract

本发明公开了作为PARP抑制剂的新型稠环化合物、其制备方法和应用。本发明的稠环化合物如式I所示。本发明的稠环化合物具有PARP抑制活性，为PARP抑制剂提供了一种新的商业选择，可用于治疗和/或预防肿瘤、中风、心肌缺血、炎症或糖尿病。

Drugs covered by this patent

Patent Metadata

Patent number
CN107573341B
Jurisdiction
CN
Classification
—
Expires
2020-08-14
Drug substance claim
No
Drug product claim
No
Assignee
Guangzhou Dankang Medicine Biological Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.